Long-Term Survival and Risk of Second Malignant Neoplasms Among Childhood Cancer Patients in 16 provinces of Spain

Background: Childhood cancer survivors have a higher risk of developing malignancies later in life compared with individuals of similar age in the general population. In Spain, population-based evidence on second malignant neoplasms (SMNs) is limited. This study aimed to estimate survival following childhood cancer diagnosis and to assess the risk of SMNs in Spain. Methods: This population-based registry study used data from 12 cancer registries within the Spanish Network of Cancer Registries (REDECAN). All malignancies of sites and non-malignant central nervous system (CNS) tumors diagnosed before age 15 were included. Age-standardized incidence rates (ASIRw) for 2015–2019 were calculated. Five- and 10-year age-adjusted observed survival rates for 1990–1999 and 2000–2009 were estimated. SMN risk was assessed using standardized incidence ratios (SIRs) and excess absolute risks (EARs). Results: The ASIRw for 2025–2019 was 181.3 per million child-years. Ten-year survival increased from 71.3% in 1990–1999 to 75.5% in 2000–2009. The overall risk of developing an SMN was significantly elevated (SIR = 5.67) at 20 years. Conclusions: Although survival for childhood cancer in Spain was around 75% in 2000–2009, childhood cancer survivors remain at substantially increased risk of SMNs for at least two decades. Efforts to reduce treatment-related toxicity while maintaining survival gains are essential.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-06-18
DOI
https://doi.org/10.3390/cancers18121991
Primary Topic
Childhood Cancer Survivors' Quality of Life
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-Term Survival and Risk of Second Malignant Neoplasms Among Childhood Cancer Patients in 16 provinces of Spain

Alberto Ameijide, Pilar Gutiérrez, Marià Carulla, Jaume Galcerán et al.
Cancers
Childhood Cancer Survivors' Quality of Life
article

Long-Term Survival and Risk of Second Malignant Neoplasms Among Childhood Cancer Patients in 16 provinces of Spain

Alberto Ameijide, Pilar Gutiérrez, Marià Carulla, Jaume Galcerán, Ramón Clèries, An Lieve Dirk Boone, Marcela Guevara, Jan Trallero, A. Vizcaino-Batllés, María‐José Sánchez, Noura Jeghalef El Karoui, Jàmnica Bigorra, Amaia Onaindia, Silvia Sanclemente, Xitama Álvarez, Isabel Martín, Antonia Sánchez, María-Isabel Palacios, Montserrat Garrido, on behalf of the Spanish Network of Cancer Registries (REDECAN)
article en

Abstract

Background: Childhood cancer survivors have a higher risk of developing malignancies later in life compared with individuals of similar age in the general population. In Spain, population-based evidence on second malignant neoplasms (SMNs) is limited. This study aimed to estimate survival following childhood cancer diagnosis and to assess the risk of SMNs in Spain. Methods: This population-based registry study used data from 12 cancer registries within the Spanish Network of Cancer Registries (REDECAN). All malignancies of sites and non-malignant central nervous system (CNS) tumors diagnosed before age 15 were included. Age-standardized incidence rates (ASIRw) for 2015–2019 were calculated. Five- and 10-year age-adjusted observed survival rates for 1990–1999 and 2000–2009 were estimated. SMN risk was assessed using standardized incidence ratios (SIRs) and excess absolute risks (EARs). Results: The ASIRw for 2025–2019 was 181.3 per million child-years. Ten-year survival increased from 71.3% in 1990–1999 to 75.5% in 2000–2009. The overall risk of developing an SMN was significantly elevated (SIR = 5.67) at 20 years. Conclusions: Although survival for childhood cancer in Spain was around 75% in 2000–2009, childhood cancer survivors remain at substantially increased risk of SMNs for at least two decades. Efforts to reduce treatment-related toxicity while maintaining survival gains are essential.

CancersVol. 18(12)
Universitat de Girona (ES), Catalan Institute for Water Research (ES), Gobierno del Principado de Asturias (ES), Basque Government (ES), Bellvitge University Hospital (ES), Generalitat Valenciana (ES), Instituto de Salud Pública de Navarra (ES), Institut d'Investigació Biomédica de Bellvitge (ES), Clínica Girona (ES), Canary Institute of Cancer Research (ES), Regional Health (US), Institut Català d'Oncologia (ES), Navarre Institute of Health Research (ES), Technological Institute of Castilla y León (ES), Institut d'Investigació Biomèdica de Girona (ES), Instituto de Investigación Biosanitaria de Granada (ES), Junta de Castilla y León (ES), Hospital General Universitari de Castelló (ES), Institut de Recerca en Energia de Catalunya (ES), Instituto Murciano de Investigación Biosanitaria (ES), Hospital Universitari Sant Joan de Reus (ES), Hospital Universitari Joan XXIII de Tarragona (ES), Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES), Gobierno de La Rioja (ES), Andalusian School of Public Health (ES), Universitat de Barcelona (ES), Universidad de Murcia (ES)
Good health and well-being
Openalex Percentile: Top 4%
Childhood Cancer Survivors' Quality of Life
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.